Investor Files Securities Suit Over $952M Albireo Merger

By Jade Martinez-Pogue (January 24, 2023, 6:57 PM EST) -- An Albireo Pharma investor on Tuesday sued the biotechnology company and its board of directors in federal court, accusing them of violating securities laws by filing an incomplete and misleading recommendation statement in connection with the planned sale of the business to a French pharmaceutical company....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!